Search Results - "SUZHAN ZHANG"

Refine Results
  1. 1

    Ferroptosis in Cancer Treatment: Another Way to Rome by Wu, Yinan, Yu, Chengcheng, Luo, Meng, Cen, Chen, Qiu, Jili, Zhang, Suzhan, Hu, Kaimin

    Published in Frontiers in oncology (25-09-2020)
    “…Ferroptosis is a newly described type of programmed cell death and intensively related to both maintaining homeostasis and the development of diseases,…”
    Get full text
    Journal Article
  2. 2

    Prognostic role of the neutrophil–lymphocyte ratio in renal cell carcinoma: a meta-analysis by Hu, Kaimin, Lou, Lixia, Ye, Juan, Zhang, Suzhan

    Published in BMJ open (08-04-2015)
    “…Objective Increasing evidence suggests that cancer-associated inflammation is associated with poor prognosis in patients with cancer. The role of the…”
    Get full text
    Journal Article
  3. 3

    Comparison of changes in lipid profiles of premenopausal women with early-stage breast cancer treated with different endocrine therapies by Wang, Kaiyue, Shen, Lu, Tian, Wei, Zhang, Suzhan

    Published in Scientific reports (31-12-2022)
    “…Adjuvant endocrine therapy improves the prognosis of early breast cancer with hormone receptor positivity. However, there is no systematic report on the effect…”
    Get full text
    Journal Article
  4. 4

    Association between Oxidative DNA Damage and Risk of Colorectal Cancer: Sensitive Determination of Urinary 8-Hydroxy-2′-deoxyguanosine by UPLC-MS/MS Analysis by Guo, Cheng, Li, Xiaofen, Wang, Rong, Yu, Jiekai, Ye, Minfeng, Mao, Lingna, Zhang, Suzhan, Zheng, Shu

    Published in Scientific reports (02-09-2016)
    “…Oxidative DNA damage plays crucial roles in the pathogenesis of numerous diseases including cancer. 8-hydroxy-2′-deoxyguanosine (8-OHdG) is the most…”
    Get full text
    Journal Article
  5. 5

    The Role of lncRNAs in the Distant Metastasis of Breast Cancer by Wu, Yinan, Shao, Anwen, Wang, Liangliang, Hu, Kaimin, Yu, Chengcheng, Pan, Chi, Zhang, Suzhan

    Published in Frontiers in oncology (31-05-2019)
    “…Breast cancer (BC) remains the most frequently diagnosed cancer worldwide. Among breast cancer patients, distant metastasis and invasion is the leading cause…”
    Get full text
    Journal Article
  6. 6

    Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer by Hu, Wangxiong, Yang, Yanmei, Li, Xiaofen, Huang, Minran, Xu, Fei, Ge, Weiting, Zhang, Suzhan, Zheng, Shu

    Published in Molecular cancer research (01-03-2018)
    “…Increasing evidence suggests that left-sided colon cancer (LCC) and right-sided colon cancer (RCC) are emerging as two different colorectal cancer types with…”
    Get full text
    Journal Article
  7. 7

    Dual targeted therapy with pyrotinib and trastuzumab for HER2‐positive advanced colorectal cancer: A phase 2 trial by Fu, Xianhua, Ying, Jieer, Yang, Liu, Fang, Weijia, Han, Weidong, Hu, Hanguang, Zhang, Suzhan, Yuan, Ying

    Published in Cancer science (01-03-2023)
    “…This trial was initiated to evaluate the efficacy and safety of pyrotinib in combination with trastuzumab in patients with human epidermal growth factor…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis by Wang, Yanyan, Zhang, Yujie, Pan, Chi, Ma, Feixia, Zhang, Suzhan

    Published in PloS one (23-02-2015)
    “…MicroRNA-21 (miRNA-21 or miR-21) may act as a prognostic biomarker of cancer. However, the available evidence is controversial. Therefore, the present…”
    Get full text
    Journal Article
  10. 10

    Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer by Shan, Jianzhen, Xuan, Yanyan, Zhang, Qi, Zhu, Chunpeng, Liu, Zhen, Zhang, Suzhan

    Published in Protein & cell (01-08-2016)
    “…Oxaliplatin is a key drug in chemotherapy of colorectal cancer (CRC). However, its efficacy is unsatisfied due to drug resistance of cancer ceils. In this…”
    Get full text
    Journal Article
  11. 11

    Mechanisms and Therapeutic Targets of Depression After Intracerebral Hemorrhage by Wu, Yinan, Wang, Liangliang, Hu, Kaimin, Yu, Chengcheng, Zhu, Yuanhan, Zhang, Suzhan, Shao, Anwen

    Published in Frontiers in psychiatry (17-12-2018)
    “…The relationship between depression and intracerebral hemorrhage (ICH) is complicated. One of the most common neuropsychiatric comorbidities of hemorrhagic…”
    Get full text
    Journal Article
  12. 12
  13. 13

    PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway by Lei, Zhong, Duan, Huijie, Zhao, Tengfei, Zhang, Yuxiang, Li, Guoqi, Meng, Jiahong, Zhang, Suzhan, Yan, Weiqi

    Published in Cell death & disease (07-03-2018)
    “…Osteosarcoma (OS) is the most common primary malignant bone tumor mainly occurring in children and adolescents. In past decades, studies revealed that PARK2…”
    Get full text
    Journal Article
  14. 14

    Potential application of the oxidative nucleic acid damage biomarkers in detection of diseases by Guo, Cheng, Ding, Peili, Xie, Cong, Ye, Chenyang, Ye, Minfeng, Pan, Chi, Cao, Xiaoji, Zhang, Suzhan, Zheng, Shu

    Published in Oncotarget (26-09-2017)
    “…Reactive oxygen species (ROS) are generated after exposure to harmful environmental factors and during normal cellular metabolic processes. The balance of the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Common genetic variation in ETV6 is associated with colorectal cancer susceptibility by Wang, Meilin, Gu, Dongying, Du, Mulong, Xu, Zhi, Zhang, Suzhan, Zhu, Lingjun, Lu, Jiachun, Zhang, Rui, Xing, Jinliang, Miao, Xiaoping, Chu, Haiyan, Hu, Zhibin, Yang, Lei, Tang, Cuiju, Pan, Lei, Du, Haina, Zhao, Jian, Du, Jiangbo, Tong, Na, Sun, Jielin, Shen, Hongbing, Xu, Jianfeng, Zhang, Zhengdong, Chen, Jinfei

    Published in Nature communications (05-05-2016)
    “…Genome-wide association studies (GWASs) have identified multiple susceptibility loci for colorectal cancer, but much of heritability remains unexplained. To…”
    Get full text
    Journal Article
  17. 17

    The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment by Hu, Kaimin, Lou, Lixia, Tian, Wei, Pan, Tao, Ye, Juan, Zhang, Suzhan

    Published in PloS one (08-07-2016)
    “…Breast cancer is a worldwide threat to female health with patient outcomes varying widely. The exact correlation between global outcomes of breast cancer and…”
    Get full text
    Journal Article
  18. 18

    Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers by XIAOCHENWANG, XIYONGLIU, LIJUN XUE, BINGSEN ZHOU, LUN ZHOU, SHU ZHENG, PEIGUO CHU, SUZHAN ZHANG, KONG ANN, David, YUN YEN, LI, Angelaying-Jian, CHEN, Lirong, LAI, Lily, LIN, Her Helen, SHUYA HU, LIFANG YAO, JIAPING PENG, LOERA, Sofia

    Published in Clinical cancer research (15-04-2011)
    “…This study aims to address the hypothesis that the high-mobility group A2 (HMGA2), an oncofetal protein, relates to survivability and serves as a prognostic…”
    Get full text
    Journal Article
  19. 19

    Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018) by Xu, Jianmin, Fan, Jia, Qin, Xinyu, Cai, Jianqiang, Gu, Jin, Wang, Shan, Wang, Xishan, Zhang, Suzhan, Zhang, Zhongtao

    “…The liver is the most common anatomical site for hematogenous metastases of colorectal cancer, and colorectal liver metastases is one of the most difficult and…”
    Get full text
    Journal Article
  20. 20

    PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer by Duan, Huijie, Lei, Zhong, Xu, Fei, Pan, Tao, Lu, Demin, Ding, Peili, Zhu, Chunpeng, Pan, Chi, Zhang, Suzhan

    Published in Frontiers in oncology (23-08-2019)
    “…mutation is originally associated with the progression of Parkinson's disease. In recent years, has been reported as a tumor suppressor gene in various…”
    Get full text
    Journal Article